Connection

SRIDEVI DEVARAJ to Atherosclerosis

This is a "connection" page, showing publications SRIDEVI DEVARAJ has written about Atherosclerosis.
Connection Strength

1.773
  1. To Fast or Not to Fast?: Comments on the Consensus Statement From the European Atherosclerosis Society/European Federation of Clinical Chemistry and Laboratory Medicine. Arch Pathol Lab Med. 2017 04; 141(4):487-489.
    View in: PubMed
    Score: 0.317
  2. Leptin: the missing link between obesity and heart disease? Atherosclerosis. 2011 Aug; 217(2):322-3.
    View in: PubMed
    Score: 0.211
  3. Therapy and clinical trials. Curr Opin Lipidol. 2007 Aug; 18(4):479-81.
    View in: PubMed
    Score: 0.162
  4. The effect of weight loss and dietary fatty acids on inflammation. Curr Atheroscler Rep. 2006 Nov; 8(6):477-86.
    View in: PubMed
    Score: 0.154
  5. Native pentameric C-reactive protein displays more potent pro-atherogenic activities in human aortic endothelial cells than modified C-reactive protein. Atherosclerosis. 2006 Jan; 184(1):48-52.
    View in: PubMed
    Score: 0.146
  6. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol. 2005 Jul; 25(7):1359-63.
    View in: PubMed
    Score: 0.139
  7. Performance of novel low-density lipoprotein-cholesterol calculation methods in predicting clinical and subclinical atherosclerotic cardiovascular disease risk: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2021 06; 327:1-4.
    View in: PubMed
    Score: 0.105
  8. Recent AHA/ACC guidelines on cholesterol management expands the role of the clinical laboratory. Clin Chim Acta. 2019 Aug; 495:82-84.
    View in: PubMed
    Score: 0.091
  9. Testing the role of myeloid cell glucose flux in inflammation and atherosclerosis. Cell Rep. 2014 Apr 24; 7(2):356-365.
    View in: PubMed
    Score: 0.065
  10. Inflammation, atherosclerosis, and psoriasis. Clin Rev Allergy Immunol. 2013 Apr; 44(2):194-204.
    View in: PubMed
    Score: 0.060
  11. Dysfunctional endothelial progenitor cells in metabolic syndrome. Exp Diabetes Res. 2012; 2012:585018.
    View in: PubMed
    Score: 0.054
  12. Statin therapy in metabolic syndrome and hypertension post-JUPITER: what is the value of CRP? Curr Atheroscler Rep. 2011 Feb; 13(1):31-42.
    View in: PubMed
    Score: 0.052
  13. Effect of tocopheryl phosphate on key biomarkers of inflammation: Implication in the reduction of atherosclerosis progression in a hypercholesterolaemic rabbit model. Clin Exp Pharmacol Physiol. 2010 May; 37(5-6):587-92.
    View in: PubMed
    Score: 0.048
  14. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation. 2006 May 02; 113(17):2135-50; discussion 2150.
    View in: PubMed
    Score: 0.037
  15. C-reactive protein and the vascular endothelium: implications for plaque instability. J Am Coll Cardiol. 2006 Apr 04; 47(7):1379-81.
    View in: PubMed
    Score: 0.037
  16. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes. 2006 Mar; 55(3):774-9.
    View in: PubMed
    Score: 0.037
  17. Sources of CRP in atherosclerotic lesions. Am J Pathol. 2006 Mar; 168(3):1054-5; author reply 1055-6.
    View in: PubMed
    Score: 0.037
  18. Simvastatin reduces circulating plasminogen activator inhibitor 1 activity in volunteers with the metabolic syndrome. Metab Syndr Relat Disord. 2008 Jun; 6(2):149-52.
    View in: PubMed
    Score: 0.011
  19. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol. 2005 Oct; 25(10):2216-21.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.